1-3 of 3
Gabriella Galffy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT005: AEGEAN: A phase 3 trial of neoadjuvant durvalumab + chemotherapy followed by adjuvant durvalumab in patients with resectable NSCLC

John V. Heymach, David Harpole, Tetsuya Mitsudomi, Janis M. Taube, Gabriella Galffy, Maximilian Hochmair, Thomas Winder, Ruslan Zukov, Gabriel Garbaos, Shugeng Gao, Hiroaki Kuroda, Jian You, Kang-Yun Lee, Lorenzo Antonuzzo, Mike Aperghis, Gary J. Doherty, Helen Mann, Tamer M. Fouad, Martin Reck
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): CT005.
https://doi.org/10.1158/1538-7445.AM2023-CT005
Published: 29 May 2023
View article titled, Abstract CT005: AEGEAN: A phase 3 trial of neoadjuvant durvalumab + chemotherapy followed by adjuvant durvalumab in patients with resectable NSCLC
Journal Articles

Abstract CT533: Durvalumab (D) plus tremelimumab (T) in platinum-refractory/resistant extensive-stage small cell lung cancer (ES-SCLC): Efficacy, safety and ctDNA dynamics from Arm A of the phase 2 BALTIC study

Niels Reinmuth, Oscar Juan-Vidal, Zsolt Horváth, Dariusz Kowalski, Anna Kryzhanivska, Eszter Csánky, Gabriella Gálffy, Maciej Bryl, David Vicente, Ihor Vynnychenko, Zsolt Pápai-Székely, Jon Armstrong, Tapashi Dalvi, Yashaswi Shrestha, Mingchao Xie, Haiyi Jiang, Igor Bondarenko
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT533.
https://doi.org/10.1158/1538-7445.AM2022-CT533
Published: 15 June 2022
View article titled, Abstract CT533: Durvalumab (D) plus tremelimumab (T) in platinum-refractory/resistant extensive-stage small cell lung cancer (ES-SCLC): Efficacy, safety and ctDNA dynamics from Arm A of the phase 2 BALTIC study
Journal Articles

Interleukin 8: An Autocrine Growth Factor for Malignant Mesothelioma

Gabriella Galffy, Kamal A. Mohammed, Patrick A. Dowling, Najmunnisa Nasreen, Melissa J. Ward, Veena B. Antony
Journal: Cancer Research
Cancer Res (1999) 59 (2): 367–371.
Published: 15 January 1999
View article titled, Interleukin 8: <subtitle>An Autocrine Growth Factor for Malignant Mesothelioma</subtitle>
Open the PDF for Interleukin 8: <subtitle>An Autocrine Growth Factor for Malignant Mesothelioma</subtitle> in another window